Clinical Trial Update: A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD [Phase 4]

View source ↗

Summary

Phase 4 safety/tolerability and pharmacokinetic study in children evaluating Azstarys for ADHD. The document notes safety and PK findings from a completed trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Azstarys (serdexmethylphenidate/dexmethylphenidate)

Snippet

Sponsor: Corium, Inc. | Conditions: Attention Deficit/Hyperactivity Disorder | Phase 4 | Status: COMPLETED